Author

Vivien B. MacLachlan

Observed names: V MacLachlan, V. B. MACLACHLAN, V. MACLACHLAN, V. MacLachlan, V. Maclachlan, V.B. MacLachlan, VIVIEN MacLACHLAN, Vivien MACLACHLAN, Vivien MacLACHLAN, Vivien MacLachlan

Institution: Monash IVF

Observed institutions: Royal Children's Hospital, Royal Women's Hospital, Epworth Hospital, Helsinki University Hospital, Monash Medical Centre, Monash Health, Monash IVF, Monash University

OpenAlex ID: A5045272239

Effect of intramural, subserosal, and submucosal uterine fibroids on the outcome of assisted reproductive technology treatment

1998 · Talia Eldar-Geva, Simon Meagher, et al. · Fertility and Sterility · 322

PDF

A Prospective Study of Inhibin in Granulosa Cell Tumors of the Ovary

1994 · Tom Jobling, Pamela Mamers, et al. · Gynecologic Oncology · 105

Recruitment of Follicles by Recombinant Human Follicle-Stimulating Hormone Commencing in the Luteal Phase of the Ovarian Cycle

1998 · Luk Rombauts, Anne-Maria Suikkari, et al. · Fertility and Sterility · 88

Double-blind placebo controlled study: human biosynthetic growth hormone for assisted reproductive technology

1996 · Anne-Maria Suikkari, Vivien MacLachlan, et al. · Fertility and Sterility · 77

Maternal serum inhibin A concentrations in early pregnancy after IVF and embryo transfer reflect the corpus luteum contribution and pregnancy outcome

2000 · Chatchai Treetampinich, Anne E. O'Connor, et al. · Human Reproduction · 74

Can you ever collect too many oocytes?

2014 · R. Briggs, G. Kovacs, et al. · Human Reproduction · 73

A Controlled Study of Luteinizing Hormone–Releasing Hormone Agonist (Buserelin) for the Induction of Folliculogenesis before in Vitro Fertilization

1989 · Vivien MacLachlan, Mandy Besanko, et al. · New England Journal of Medicine · 71

Relationship between Serum Inhibin A and B and Ovarian Follicle Development after a Daily Fixed Dose Administration of Recombinant Follicle-Stimulating Hormone

2000 · T. Eldar-Geva, D. M. Robertson, et al. · The Journal of Clinical Endocrinology & Metabolism · 69

Serum Inhibin Levels in Polycystic Ovary Syndrome: Basal Levels and Response to Luteinizing Hormone-Releasing Hormone Agonist and Exogenous Gonadotropin Administration*

1988 · H. M. BUCKLER, R. I. McLACHLAN, et al. · The Journal of Clinical Endocrinology & Metabolism · 68

The success rate of IVF has significantly improved over the last decade

2015 · Jessica J. Wade, Vivien MacLachlan, et al. · Australian and New Zealand Journal of Obstetrics and Gynaecology · 55

Predicting pregnancy outcome after in vitro fertilization and embryo transfer using estradiol, progesterone, and human chorionic gonadotropin β-subunit

1989 · Takanori Yamashita, Sumihide Okamoto, et al. · Fertility and Sterility · 44

Sex ratio and birth weights of infants born as a result of blastocyst transfers compared with early cleavage stage embryo transfers

2001 · Annette Kausche, Gayle M Jones, et al. · Fertility and Sterility · 41

PDF

Is the luteo-placental shift a myth? Analysis of low progesterone levels in successful art pregnancies

1993 · K Azuma, I Calderon, et al. · The Journal of Clinical Endocrinology & Metabolism · 28

Replacement of one selected embryo is just as successful as two embryo transfer, without the risk of twin pregnancy

2003 · Gab Kovacs, Vivien MacLachlan, et al. · Australian and New Zealand Journal of Obstetrics and Gynaecology · 26

A controlled study of gonadotropin-releasing hormone agonist (buserelin acetate ) for folliculogenesis in routine in vitro fertilization patients

1991 · David W. Polson, Vivien MacLachlan, et al. · Fertility and Sterility · 25

Serum immunoactive inhibin levels in early pregnancy after in vitro fertilization and embryo transfer

1993 · Takashi Yohkaichiya, David W. Polson, et al. · Fertility and Sterility · 24

School-age outcomes among IVF-conceived children: A population-wide cohort study

2023 · Amber L. Kennedy, Beverley J. Vollenhoven, et al. · PLoS Medicine · 23

PDF

Do raised serum luteinizing hormone levels during stimulation for in‐vitro fertilization predict outcome?

1989 · A. THOMAS, S. OKAMOTO, et al. · BJOG An International Journal of Obstetrics & Gynaecology · 23

Endocrinology: Ultrasonographic appearance of polycystic ovaries is associated with exaggerated ovarian androgen and oestradiol responses to gonadotrophin-releasing hormone agonist in women undergoing assisted reproduction treatment

1995 · Anne-Maria Suikkari, Vivien MacLachlan, et al. · Human Reproduction · 22

What is the probability of conception for couples entering an IVF program?

2001 · GT Kovacs, V MacLachlan, et al. · Australian and New Zealand Journal of Obstetrics and Gynaecology · 18

Should intrauterine human chorionic gonadotropin infusions ever be used prior to embryo transfer?

2017 · Michelle Volovsky, Martin Healey, et al. · Journal of Assisted Reproduction and Genetics · 17

The incidence of hypertensive disorders of pregnancy following sperm donation in IVF: an Australian state-wide retrospective cohort study

2019 · Amber L Kennedy, Cathryn J Stern, et al. · Human Reproduction · 16

PDF

The Effects of Adjuvant Therapies on Embryo Transfer Success.

2017 · Rachael Shirlow, Martin Healey, et al. · Europe PMC (PubMed Central) · 14

Outcome of pregnancies achieved by in vitro fertilisation techniques and diagnosed as twins at the 6 week ultrasound

2004 · Gabor T. KOVACS, Sue BREHENY, et al. · Australian and New Zealand Journal of Obstetrics and Gynaecology · 6

Intrauterine human chorionic gonadotropin (HCG) infusion prior to embryo transfer (ET) may be detrimental to pregnancy rate

2016 · M. Volovsky, M. Healey, et al. · Fertility and Sterility · 4

PDF

Works count: 41

Citation count: 1,348

H-index: 19

I10-index: 23